HLA-DQB1*0201: A marker for good prognosis in British and Dutch patients with sarcoidosis

American Journal of Respiratory Cell and Molecular Biology

Volumn 27, Issue 4, 2002, Pages 406-412

  Sato, Hiroe ^a   Grutters, Jan C ^a   Pantelidis, Panagiotis ^a   Mizzon, A Neil ^a   Ahmad, Tariq ^a   Van Houte, Arend Jan ^a   Lammers, Jan Willem J ^a   Van den Bosch, Jules M M ^a   Welsh, Kenneth I ^a   Du Bois, Roland M ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; CARBON MONOXIDE; DDX39 PROTEIN, HUMAN; DEAD BOX PROTEIN; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DQB1 ANTIGEN; LYMPHOTOXIN; NFKBIL1 PROTEIN, HUMAN; RNA HELICASE; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; DISEASE COURSE; GENETIC MARKER; GENETIC POLYMORPHISM; GENETICS; HAPLOTYPE; HUMAN; LUNG FUNCTION TEST; METABOLISM; NETHERLANDS; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PROGNOSIS; SARCOIDOSIS; SYNDROME; TIME; UNITED KINGDOM;

ALLELES; ATP-BINDING CASSETTE TRANSPORTERS; CARBON MONOXIDE; DEAD-BOX RNA HELICASES; DISEASE PROGRESSION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENETIC MARKERS; GREAT BRITAIN; HAPLOTYPES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DQ ANTIGENS; HUMANS; LYMPHOTOXIN-ALPHA; NETHERLANDS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROGNOSIS; RESPIRATORY FUNCTION TESTS; RNA HELICASES; SARCOIDOSIS; SYNDROME; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036771767     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.4782     Document Type: Article

References (24)

1. Newman, L. S., C. S. Rose, and L. A. Maier. 1997. Sarcoidosis. N. Engl. J. Med. 336:1224-1234.
2. Tazi, A., I. Fajac, P. Soler, D. Valeyre, J. P. Battesti, and A. J. Hance. 1991. Gamma/delta T-lymphocytes are not increased in number in granulomatous lesions of patients with tuberculosis or sarcoidosis. Am. Rev. Respir. Dis. 144:1373-1375.
3. Klein, J., and A. Sato. 2000. The HLA system. First of two parts. N. Engl. J. Med. 343:702-709.
4. Klein, J., and A. Sato. 2000. The HLA system. Second of two parts. N. Engl. J. Med. 343:782-786.
5. McGrath, D. S., N. Goh, P. J. Foley, and R. M. du Bois. 2001. Sarcoidosis: genes and microbes: soil or seed? Sarcoidosis. Vasc. Diffuse. Lung Dis. 18:149-164.
6. du Bois, R. M. 2001. Sarcoidosis: do our genes really matter? Am. J. Respir. Crit Care Med. 164:725-726.
7. Rybicki, B. A., M. J. Maliarik, M. Major, J. Popovich. Jr., and M. C. Iannuzzi. 1997. Genetics of sarcoidosis. Clin Chest Med. 18:707-717.
8. Luisetti. M., A. Beretta, and L. Casali. 2000. Genetic aspects in sarcoidosis. Eur. Respir. J. 16:768-780.
9. Schürmann, M., G. Bein, D. Kirsten, M. Schlaak, J. Müller-Quernheim, and E. Schwinger. 1998. HLA-DQB1 and HLA-DPB1 genotypes in familial sarcoidosis. Respir. Med. 92:649-652.
10. Pasturenzi, L., M. Martinetti, M. Cuccia. A. Cipriani, G. Semenzato. and M. Luisetti. 1993. HLA Class I, II, and III polymorphism in Italian patients with sarcoidosis. The Pavia-Padova Sarcoidosis Study Group. Chest 104:1170-1175.
11. Schürmann, M., P. Reichel, B. Müller-Myhsok. M. Schlaak, J. Müller-Quernheim, and E. Schwinger. 2001. Results from a genome-wide search for predisposing genes in sarcoidosis. Am. J. Respir. Crit Cure Med. 164:840-846.
12. Ishihara, M., T. Ishida, H. Inoko, H. Ando, T. Naruse, Y. Nose, and S. Ohno. 1996. HLA serological and Class II genotyping in sarcoidosis patients in Japan. Jpn. J. Ophthalmol. 40:86-94.
13. Ishihara, M., H. Inoko, K. Suzuki, H. Ono, Y. Hiraga, H. Ando, T. Naruse, T. Ishida, and S. Ohno. 1996. HLA Class II genotyping of sarcoidosis patients in Hokkaido by PCR-RFLP. Jpn. J. Ophthalmol. 40:540-543.
14. Nowack, D. and K. M. Goebel. 1987. Genetic aspects of sarcoidosis. Class II histocompatibility antigens and a family study. Arch. Intern. Med 147:481-483.
15. Swider, C., L. Schnittger, K. Bogunia-Kubik, J. Gerdes, H. Flad, A. Lange, and U. Seitzer. 1999. TNF-alpha and HLA-DR genotyping as potential prognostic markers in pulmonary sarcoidosis. Eur. Cytokine Netw. 10:143-146.
16. Berlin, M., A. Fogdell-Hahn, O. Olerup, A. Eklund, and J. Grunewald. 1997. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am. J. Respir. Crit Care Med. 156:1601-1605.
17. Bogunia-Kubik, K., J. Tomeczko, K. Suchnicki, and A. Lange. 2001. HLA-DRB1*03, DRB1*11 or DRB1*12 and their respective DRB3 specificities in clinical variants of sarcoidosis. Tissue Antigens 57:87-90.
18. Foley, P. J., D. S. McGrath, E. Puscinska, M. Petrek, V. Kolek, J. Drabek, P. A. Lympany, P. Pantelidis, K. I. Welsh, J. Zielinski, and R. M. du Bois. 2001. Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis. Am. J Respir. Cell Mol. Biol. 25:272-277.
19. Ishihara, M., S. Ohno, T. Ishida, H. Ando, T. Naruse, Y. Nose, and H. Inoko. 1994. Molecular genetic studies of HLA Class II alleles in sarcoidosis. Tissue Antigens 43:238-241.
20. Naruse, T. K., Y. Matsuzawa, M. Ota, Y. Katsuyama, A. Matsumori, M. Hara, S. Nagai, S. Morimoto, S. Sasayama, and H. Inoko. 2000. HLA-DQB1*0601 is primarily associated with the susceptibility to cardiac sarcoidosis. Tissue Antigens 56:52-57.
21. Bunce, M., C. M. O'Neill, M. C. Barnardo, P. Krausa, M. J. Browning, P. J. Morris, and K. I. Welsh. 1995. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 46:355-367.
22. Tang, W. M., J. S. Pulido, D. D. Eckels. D. P. Han, W. F. Mieler, and K. Pierce. 1997. The association of HLA-DR15 and intermediate uveitis. Am. J. Ophthalmol. 123:70-75.
23. Brown, J. H., T. S. Jardetzky, J. C. Gorga, L. J. Stern, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1993. Three-dimensional structure of the human Class II histocompatibility antigen HLA-DR1. Nature 364:33-39.
24. Falk, K., O. Rotzschke, S. Stevanovic, G. Jung, and H. G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of setf-peptides eluted from MHC molecules. Nature 351:290-296.